학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 132건 | 목록 1~10
Academic Journal
O'Regan RM; University of Rochester Department of Medicine, Rochester, New York.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, California.; Fleming GF; The University of Chicago Medical Center, Chicago, Illinois.; Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia & New Zealand, Newcastle, Australia.; University of Newcastle, Callaghan, Newcastle, Australia.; Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Viale G; International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy.; Dell'Orto P; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy.; Lang I; Clinexpert-Research, Budapest, Hungary.; Bellet M; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Bonnefoi HR; Institut Bergonie Comprehensive Cancer Center, Universite de Bordeaux, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy.; Villa F; Oncology Unit, Department of Oncology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy.; Bernardo A; Operative Unit of Medical Oncology, IRCCS ICS Maugeri, Pavia, Italy.; Ciruelos EM; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; Neven P; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ Leuven, KU Leuven, Leuven, Belgium.; Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile.; Jochum W; Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Zaman K; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Breast Center, Lausanne University Hospital CHUV, Lausanne, Switzerland.; Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas.; Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh, Pennsylvania.; NSABP Foundation/NRG Oncology, Pittsburgh, Pennsylvania.; Jerzak KJ; Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.; Davidson NE; Fred Hutchinson Cancer Center, University of Washington Seattle, Washington.; ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania.; Coleman RE; Weston Park Hospital, Sheffield, United Kingdom.; National Cancer Research Institute, Breast Cancer Clinical Studies Group (NCRI-BCSG), London, United Kingdom.; The Institute for Cancer Research, The Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom.; Ingle JN; Mayo Clinic and Alliance for Clinical Trials in Oncology, Rochester, Minnesota.; van Mackelenbergh MT; German Breast Group, Neu Isenburg, Germany.; University Hospital of Schleswig-Holstein, Campus Kiel, Germany.; Loi S; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia.; Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California.; Treuner K; Biotheranostics, A Hologic Company, San Diego, California.; Regan MM; IBCSG Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Academic Journal
Foldi J; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Carleton N; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, PA, USA.; Anderson SJ; Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.; Rastogi P; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, the University of Pittsburgh School of Medicine, and NSABP Foundation, Inc., Pittsburgh, PA, USA.; Lee A; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, PA, USA.; Magee-Womens Research Institute, Pittsburgh, PA, USA.; Balic M; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, the University of Pittsburgh School of Medicine, and NSABP Foundation, Inc., Pittsburgh, PA, USA.; Geyer CE Jr; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, the University of Pittsburgh School of Medicine, and NSABP Foundation, Inc., Pittsburgh, PA, USA.; Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, PA, USA.; Magee-Womens Research Institute, Pittsburgh, PA, USA.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.; Wolmark N; UPMC Hillman Cancer Center, the University of Pittsburgh School of Medicine, and NSABP Foundation, Inc., Pittsburgh, PA, USA.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Rastogi P; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Magee-Women's Hospital, Pittsburgh, PA.; Bandos H; NRG Oncology SDMC, Pittsburgh, PA.; University of Pittsburgh, School of Public Health, Pittsburgh, PA.; Lucas PC; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; van 't Veer LJ; Agendia, Inc, Irvine, CA.; Wei JJ; Agendia, Inc, Irvine, CA.; Geyer CE Jr; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Fehrenbacher L; Kaiser Permanente Oncology Clinical Trials Northern CA, Novato, CA.; Chia SKL; British Columbia Cancer Agency, Vancouver, BC, Canada.; Brufsky AM; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Magee-Women's Hospital, Pittsburgh, PA.; Walshe JM; Cancer Trials Ireland, and St Vincent's University Hospital, Dublin, Ireland.; Soori GS; Florida Cancer Specialists, Fort Myers, FL.; Dakhil SR; 0Wichita NCORP, Via Christi Regional Medical Center, and Cancer Center of Kansas, Wichita, KS.; Paik S; 1Theragenbio, Inc, Pankyo, Republic of Korea.; 2Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.; Swain SM; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Menicucci AR; Agendia, Inc, Irvine, CA.; Audeh MW; Agendia, Inc, Irvine, CA.; Wolmark N; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Mamounas EP; Advent Health Cancer Center, Orlando, FL.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Mamounas EP; Orlando Health Cancer Institute, Orlando, Florida.; Bandos H; NRG Oncology SDMC, and the University of Pittsburgh, Pittsburgh, Pennsylvania.; Rastogi P; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Magee-Womens Hospital, Pittsburgh, Pennsylvania.; Zhang Y; Biotheranostics, Inc., A Hologic Company, San Diego, California.; Treuner K; Biotheranostics, Inc., A Hologic Company, San Diego, California.; Lucas PC; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Geyer CE Jr; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Fehrenbacher L; Kaiser Permanente Oncology Clinical Trials Northern CA, Novato, California.; Chia SK; British Columbia Cancer Agency, and the University of British Columbia, Vancouver, British Columbia, Canada.; Brufsky AM; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Magee-Womens Hospital, Pittsburgh, Pennsylvania.; Walshe JM; Cancer Trials Ireland (formerly known as Irish Clinical Oncology Research Group-ICORG), Dublin, Ireland.; Soori GS; Florida Cancer Specialists, Ft. Myers, Florida.; Dakhil S; CCOP Wichita/Cancer Center of Kansas, Wichita, Kansas.; Paik S; Theragenbio, Inc., Pankyo, Republic of South Korea, and Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.; Swain SM; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.; Sgroi DC; Massachusetts General Hospital, Boston, Massachusetts.; Schnabel CA; Biotheranostics, Inc., A Hologic Company, San Diego, California.; Wolmark N; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Geyer CE Jr; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Blum JL; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology Research, Dallas, TX.; Yothers G; NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA.; Asmar L; USOR, McKesson Specialty Health, The Woodlands, TX.; Flynn PJ; Minnesota Community Oncology Research Consortium (MSORC), Stone Lake, MI.; Robert NJ; Ontada, Irving, TX.; Hopkins JO; Novant Health (Forsyth Medical) Cancer Institute, Southeast Clinical Oncology Research (SCOR) NCORP, Winston Salem, NC.; O'Shaughnessy JA; Baylor University Medical Center, Texas Oncology, US Oncology Research, Dallas, TX.; Rastogi P; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; UPMC Magee-Womens Hospital, Pittsburgh, PA.; Puhalla SL; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; Hilton CJ; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; Allegheny Health Network, Pittsburgh, PA.; Dang CT; Memorial Sloan Kettering Cancer Center, West Harrison, NY.; Gómez HL; National Institute of Neoplastic Diseases, Lima, Peru.; Vukelja SJ; US Oncology Tyler Cancer Center, Tyler, TX.; Lyss AP; Heartland Cancer Research NCORP-Missouri Baptist Medical Center, St Louis, MO.; Paul D; USOR, McKesson Specialty Health, The Woodlands, TX.; Brufsky AM; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; UPMC Magee-Womens Hospital, Pittsburgh, PA.; Colangelo LH; NRG Oncology SDMC, Department of Biostatistics, and University of Pittsburgh School of Public Health, Pittsburgh, PA.; Swain SM; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC.; Mamounas EP; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; Orlando Health Cancer Institute, Orlando, FL.; Wolmark N; NSABP Foundation/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Mamounas EP; Department of Surgical Oncology, Orlando Health Cancer Institute, Orlando, FL, USA.; Bandos H; NRG Oncology SDMC, and the Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Rastogi P; University of Pittsburgh Medical Center Hillman Cancer Center, Department of Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Oncology, University of Pittsburgh Magee-Womens Hospital, Pittsburgh, PA, USA.; Lembersky BC; University of Pittsburgh Medical Center Hillman Cancer Center, Department of Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Jeong JH; NRG Oncology SDMC, and the Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.; Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center, Department of Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Fehrenbacher L; Department of Medical Oncology, Kaiser Permanente Oncology Clinical Trials Northern California, Novato, CA, USA.; Chia SK; Department of Medical Oncology, British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, Canada.; Brufsky AM; Department of Oncology, University of Pittsburgh Magee-Womens Hospital, Pittsburgh, PA, USA.; Walshe JM; Department of Oncology, Cancer Trials Ireland (formerly known as Irish Clinical Oncology Research Group-ICORG), Dublin, Ireland.; Soori GS; Department of Oncology, Florida Cancer Specialists, Fort Myers, FL, USA.; Dakhil SR; Department of Oncology, Community Clinical Oncology Program, Wichita via Christi Regional Medical Center, Wichita, KS, USA.; Wade JL 3rd; Department of Oncology, Decatur Memorial Hospital, Cancer Care Specialists of Illinois, Heartland National Cancer Institute Community Oncology Research Program, Decatur, IL, USA.; McCarron EC; Department of Surgical Oncology, MedStar Franklin Square Medical Center at Weinberg Cancer Institute, Baltimore, MD, USA.; Swain SM; Department of Surgical Oncology, Georgetown Lombardi Comprehensive Cancer Center, MedStar Health, Washington, DC, USA.; Wolmark N; NRG Oncology SDMC, and the Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Paik S; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Tang G; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Shak S; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Kim C; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Baker J; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Kim W; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Cronin M; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Baehner FL; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Watson D; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Bryant J; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Costantino JP; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Geyer CE Jr; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Wickerham DL; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.; Wolmark N; From the Division of Pathology, Operations Center, and Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project; Department of Biostatistics, School of Public Health, University of Pittsburgh; Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA; Genomic Health Inc, Redwood City, CA; and University of California, San Francisco, San Francisco, CA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Foldi J; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Geyer CE Jr; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, Pittsburgh, PA, USA. charles.geyer@nsabp.org.; NSABP Foundation, Pittsburgh, PA, USA. charles.geyer@nsabp.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9425763 Publication Model: Print Cited Medium: Internet ISSN: 1748-7838 (Electronic) Linking ISSN: 10010602 NLM ISO Abbreviation: Cell Res Subsets: MEDLINE
Academic Journal
Thomas A; Department of Internal Medicine, Atrium Health Wake Forest Baptist Cancer Center, Winston-Salem, NC, USA. althomas@wakehealth.edu.; Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Geyer CE Jr; Department of Medicine, University of Pittsburgh UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Wen HY; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Squifflet P; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; Saad ED; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; Loibl S; German Breast Group, Neu-Isenburg, Germany.; van Mackelenbergh MT; German Breast Group, Neu-Isenburg, Germany.; Untch M; Helios Kliniken Berlin-Buch, Berlin, Germany.; Rastogi P; NRG Oncology, Pittsburgh, PA.; Gianni L; San Raffaele Scientific Institute, Milan, Italy.; Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.; Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.; Piccart M; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.; Bonnefoi H; Institut Bergonié and Université de Bordeaux INSERM U916, Bordeaux, France.; Jackisch C; Sana Klinikum Offenbach, Offenbach, Germany.; Nekljudova V; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; Tang G; University of Pittsburgh, Pittsburgh, PA.; Valagussa P; Fondazione Michelangelo, Milan, Italy.; Neate C; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Gelber R; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA.; Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Heinzmann D; Product Development-Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany.; Geyer CE Jr; UPMC Hillman Cancer Center, Pittsburgh, PA.; Cortes J; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova and Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.; de Azambuja E; Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.; Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom.; Ismael G; Fundação Doutor Amaral Carvalho, Jaú, Brazil.; Wolmark N; UPMC Hillman Cancer Center, Pittsburgh, PA.; Cortazar P; Genentech, Inc, South San Francisco, CA.; Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; Data Science Institute, I-BioStat, Hasselt University, Hasselt, Belgium.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Geyer CE Jr
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어